Phase II Trial of Endoscopic Ultrasound Pancreatic Cancer Radiofrequency Ablation (PANCARDINAL-1 Trial)
The purpose of this phase II study is to evaluate the safety, feasibility, and treatment effect of Endoscopic Ultrasound (EUS) Radiofrequency ablation (RFA) plus standard-of-care of Neoadjuvant chemotherapy (NAC) in patients with pancreatic adenocarcinoma.
Study ID: HSC-MS-21-0066
Trial Phase: Phase II
Trial Sponsor: The University of Texas Health Science Center, Houston
Therapies Used in This Trial: Nab-paclitaxel, Gemcitabine, Cisplatin, FOLFIRINOX